pocketful logo light
pocketful logo light
Colinz Laboratories Ltd logo

Colinz Laboratories Ltd

NSE: BSE: 531210

62.18

(3.63%)

Wed, 24 Jun 2026, 00:42 am

Colinz Laboratories Share Price Live Chart

1 Day

(3.63%)

No Result Found

Summary

  • Market Cap (in Cr)

    6.73

  • Net Profit (in Cr)

    0.5

  • P/B

    1.93

  • Sector P/E

    44.89

  • P/E

    36.77

  • EV/EBITDA

    35.70

  • Debt/Equity (Industry)

    0.26

  • Interest Cover (Industry)

    10.81

  • ROCE (Industry)

    16.40

  • RONW (Industry)

    14.39

  • ROE

    5.43

  • ROCE

    6.72

  • Debt/Equity

    0.07

  • EPS (TTM)

    4.08

  • Dividend Yield

    0

  • Book Value

    69.70

  • Interest Cover

    16.50

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters66.0066.0066.0066.0066.00
FII00000
DII00000
Public34.0034.0034.0034.0034.00
Government00000

Read More

Technical Analysis

RSI

73.40

MACD

3.70

50 DMA

51.43

200 DMA

47.88

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic72.5961.1257.2949.6545.8238.1826.71
Fibonacci61.1256.7454.0349.6545.2742.5638.18
Camarilla56.6255.5754.5249.6552.4251.3750.32

Pivots Level: Classic

R3

+22.94

72.59

R2

+11.47

61.12

R1

+7.65

57.29

49.65
49.65
Pivot Point
LTP: 68.54

S1

-3.82

45.82

S2

-11.47

38.18

S3

-22.94

26.71

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    61.11

  • 20-EMA

    58.02

  • 30-EMA

    55.93

  • 50-EMA

    53.50

  • 100-EMA

    51.20

  • 200-EMA

    50.10

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
29 Apr 2026board-meetingsAccounts, Quarterly Results
24 Jan 2026board-meetingsQuarterly Results
03 Nov 2025board-meetingsQuarterly Results, Half Yearly Results
31 Jul 2025agm
08 Aug 2024agm
31 Jul 2023agm
01 Aug 2022agm
30 Jul 2021agm

Read More

Peer Comparison

Colinz Laboratories Ltd logo

Colinz Laboratories Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Read More

Colinz Laboratories Ltd About

Colinz Laboratories is engaged in the manufacturing and marketing of pharmaceutical formulations particularly in gynaecological sector.

Industry

Pharmaceuticals - Indian - Formulations

Founded

1986

Headquarters

CEO

Employees

Contact

Website icon

Website

http://www.colinz.com

Email icon

Email

colinz@hathway.com; cllfindoc@yahoo.com

Phone icon

Phone

91-022-25668002/8003

Location icon

Location

A-101 Pratik Industrial Estate, Mulund Goregaon Link Road, Mumbai, Maharashtra, 400078

Read More

Colinz Laboratories Ltd Company History

YearHistory
1986
  • Colinz Laboratories Ltd. was incorporated as a private limited company.
  • The Company obtained certificate of registration No. 41128 on 16th October.
1990
  • The company started its production and marketing activities.
1995
  • The Company obtained Certificate of Change of name under the Companies Act, 1956 on 5th January.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
GAURAV AGARWALbulkBuy1633884.4630 Jan 2026
BONANZA PORTFOLIO LIMITEDbulkBuy700086.9430 Jan 2026
F3 ADVISORS PRIVATE LIMITEDbulkSell1474185.9430 Jan 2026
F3 ADVISORS PRIVATE LIMITEDbulkBuy1474179.6830 Jan 2026
BONANZA PORTFOLIO LIMITEDbulkSell1426078.330 Jan 2026
KEYUR SURESHBHAI SHAHbulkBuy1370253.9909 May 2025
BHUPESH GUPTAbulkBuy1273180.9810 Jul 2024
KETAN BHAILAL SHAHbulkBuy340006.8531 Jan 2007
KETAN BHAILAL SHAHbulkSell340006.8531 Jan 2007

Read More

Colinz Laboratories Ltd News

Colinz Labs open offer at ₹54 per share

Acquirers Annjana, Likhitta, and Antariksh Dugar, along with PAC Padam Dugar, have launched an open offer to buy 26% of Colinz Laboratories at ₹54 per share, aggregating ₹3.54 crore.

18 Jun 2026

companies

Vijaya Mani sells shares in Colinz Laboratories

Promoter Vijaya Mani sold 3,78,000 shares in Colinz Laboratories via off-market transaction on May 21, 2026. Post-sale, her holding reduced to 34.56%.

25 May 2026

companies

Colinz Labs Submits FY26 Newspaper Clippings to BSE

Colinz Laboratories submitted newspaper clippings of FY26 audited results published in Free Press Journal and Navshakti on April 30, 2026, under SEBI Regulation 47(3) compliance.

30 Apr 2026

companies

Colinz Laboratories Board Approves FY26 Results

Colinz Laboratories Limited's Board approved audited financial results for FY26 on April 29, 2026. The company reported annual revenue of ₹613.61 lakhs and net profit of ₹51.45 lakhs with unmodified audit opinion.

29 Apr 2026

companies

Colinz Laboratories Reports FY26 Results

Colinz Laboratories Limited reported revenue of ₹613.61 lakh and profit of ₹51.45 lakh for FY26. The Board approved audited financial results on April 29, 2026, with unmodified audit opinion from Vora & Associates.

29 Apr 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number